Jul 16, 2024
Comments to FDA: Toll-Free Number for Reporting Adverse Events on Labeling for Human Drug Products
Docket Number:
2003N-0342
CHPA comments on the proposed rule, which is intended to bring FDA regulations into compliance with section 17 of the Best Pharmaceuticals for Children Act.
Issues: